Early consideration of potential safety liabilities is an important part of every drug discovery project. With our extensive and diverse experience of discovery and development, we have the expertise to design high quality, cost effective nonclinical safety packages that perfectly align with your project.
Working flexibly with discovery and development teams, our scientists help identify the key safety questions needed to deliver derisked compounds into clinical trials and through clinical development. We can design the overall safety strategy, deliver the toxicology /DMPK studies, author regulatory documents and support regulatory agency interactions.
